Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

A Bouquet for a Broken Heart

Can Flowers Repair a Damaged Heart?

Charles K. Thodeti
Download PDF
https://doi.org/10.1161/CIRCRESAHA.115.306590
Circulation Research. 2015;116:1729-1731
Originally published May 21, 2015
Charles K. Thodeti
From the Department of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Endocardial Flowers: A Bouquet of Arterial Endothelial Cells Generated From New and Pre-Existing Endothelial Cells Within the Endocardium of Infarcted Heart
    • Back in the Saddle: Redeployment of Developmental Mechanisms for Coronary Vessel Growth
    • Clinical Significance and Future Perspective
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading
  • Editorials
  • angiogenesis
  • coronary vessels
  • endocardium
  • endothelial cells
  • myocardial infarction

Ischemic heart disease is the major underlying cause of myocardial infarction (MI), scarring, and hypertrophy that can progress to heart failure. Each year, ≈300 000 individuals have recurring MIs, which is projected to ≈40% of the US population in the next 15 years. More recently, angiogenic therapy for myocardial ischemia has received significant attention. These therapeutic angiogenic strategies include gene therapy, delivery of growth factor proteins, and stem cell implantation.1–6 Although these approaches are attractive, there are limitations and concerns, including delivery modalities, uncontrolled angiogenesis, limited half-life of growth factors, and off-target effects on other organs.7–9 Moreover, limited success of therapeutic angiogenesis in myocardial revascularization left us with more questions than answers.9,10 Is the damaged heart capable of inducing new vessel growth? If so, what is the source of coronary vessel growth? What are the molecular mechanisms involved? Fortunately, recent studies on coronary vascular development have begun to answer these questions.

Article, see p 1765

Emerging evidence on the generation of coronary vasculature during development identified more than one source for the origin of coronary vascular endothelial cells that include epicardium, sinus venosus, and endocardium.11 Using conditional inducible Apln-Cre-ERT2-knockin mice, Tian et al12 showed that subepicardial endothelial cells are the major source of intramyocardial coronary arteries. Furthermore, using single cell labeling and clonal analysis, Red-Horse et al13 demonstrated that coronary vessels developed from sinus venosus endothelial cells via sprouting angiogenesis and dedifferentiation. In contrast, Wu et al14 found that endocardial endothelial cells significantly contribute to intramyocardial vascular endothelial cells using a Cre knockin mouse strain, Nfatc1-Cre, which showed specific expression of Nfatc1 in the endocardium but not in the endothelial cells in the myocardium. Perhaps most studies on the source of coronary vessels have focused on developmental stages. Intriguingly, recent studies by Wu et al14 revealed that the endocardium de novo forms coronary arteries in postnatal hearts, suggesting an important role for the endocardium in the origin of coronary vasculature in the postembryonic stages. However, the importance of the endocardium in the neovascularization of the myocardium in the injured/infarcted adult heart is not well known.

Endocardial Flowers: A Bouquet of Arterial Endothelial Cells Generated From New and Pre-Existing Endothelial Cells Within the Endocardium of Infarcted Heart

In this issue of Circulation Research, Miquerol et al15 investigated the role of the endocardium in the generation of new vessels in the damaged myocardium of mouse hearts. They found novel, previously undescribed, endothelial foci within the infarct zone of endocardium 7 days post MI in Connexin-40 (Cx40)-GFP (green fluorescent protein) mice. These mice express GFP only in endothelial cells of coronary arteries, but not in the endocardium, veins, or capillaries.16 These endothelial foci, termed by authors as endocardial flowers because of the appearance, exhibited a distinct arterial phenotype displaying positive expression of Cx40 and VEGFR2 (vascular endothelial growth factor receptor 2) and negative expression for endoglin (Cx40+ and VEGFR2+, Endoglin−) with accumulation of smooth muscle cells. These findings were in contrast to the surrounding endocardium, which was negative for Cx40 and VEGFR2 and positive for endoglin (Cx40− and VEGFR2−, Endoglin+). Furthermore, time course analysis of arterial marker expression revealed that VEGFR2 expression continued into the endocardium 3 days post MI, followed by the formation of endocardial flowers, which progressively acquired the arterial phenotype with increased expression of Cx40-GFP. To unequivocally confirm the genetic tracing of the endothelial lineage of endocardial flowers (ie, generated from new Cx40 expression or from pre-existing vessels), the authors used a tamoxifen-inducible Cx40-Cre-RFP (red fluorescent protein) mouse line17 crossed with R26-LacZ or R26-YFP (yellow fluorescent protein). Induction of MI in tamoxifen-injected mice generated Cx40-RFP endocardial flowers that were negative for either LacZ or YFP, suggesting that these structures resulted from arteriogenesis of Cx40 negative, endocardial cells. However, a subset of Cx40-RFP–positive endocardial flowers showed YFP-positive endothelial cells, indicating arteriogenesis may have occurred from pre-existing vessels. These findings demonstrated unprecedented endothelial plasticity between the endocardial and the coronary arterial compartment in the infarct zone. Finally, endocardial flower formation seemed to be mediated via sprouting angiogenesis from the endocardium, which contained VEGFR2 expressing tip cells, surrounded by proliferating smooth muscle and endocardial cells.

Back in the Saddle: Redeployment of Developmental Mechanisms for Coronary Vessel Growth

Although this study elegantly demonstrated the generation of new coronary vessels from a combination of endothelial cells from pre-existing arteries and endocardium de novo, two important questions remain to be answered. First, the molecular mechanism by which sprouting angiogenesis and arteriogenesis occurs from the endocardium is not known. Second, the functional significance of endocardial flowers has not been investigated. The answer to the first question can be gleaned from the findings of Wu et al,14 which may provide mechanistic insights into sprouting angiogenesis and arteriogenesis in the heart. In their study using Nfatc1-Cre mice, Wu et al14 demonstrated that in between embryonic stage 11.5 and 13.5, cells from the endocardium significantly contributed to the intramyocardial arteries. Importantly, coronary vessel formation was abolished when they knocked down VEGF-A (vascular endothelial growth factor-A) expression in the myocardium or VEGFR2 expression in the endocardium, suggesting that VEGF signaling plays a critical role in the induction of angiogenesis and coronary artery formation.14

What are the signals that trigger expression of VEGF-A in the myocardium or VEGFR2 in the endocardium? On the basis of oxygen environment in the developing embryo, Wu et al14 proposed that myocardial proliferation may trigger a VEGF-A gradient across the ventricular wall (possibly regulated by a reverse gradient of oxygen) that promotes vessel growth from VEGFR2 expressing endocardial cells. Interestingly, Zhao et al18 demonstrated that VEGF-A expression increases within an hour after MI and continued to increase for 24 hours into the border zone and endocardium, which supports a role for VEGF-A in triggering sprouting angiogenesis in the endocardium. Furthermore, the study of Zhao et al18 also demonstrated the appearance of new vessels at day 3, with a peak vascular density at day 7, correlating with the formation of endocardial flowers.18 Although oxygen levels were not measured, it is conceivable that an oxygen gradient would be present, with the highest level in the endocardium to the lowest level in the infarct zone. On the basis of these findings, a proposed molecular mechanism (Figure) could involve the generation of a VEGF-A gradient in response to the hypoxic environment at the infarct/border zone of the myocardium, which may initiate sprouting angiogenesis by VEGFR2 expressing endocardial cells. These cells then form endocardial flowers by progressively acquiring the arterial phenotype through the proliferation of endothelial cells and recruitment of smooth muscle cells. This mechanism is reminiscent of the one proposed by Wu et al14 in coronary vascular development in the embryo and strongly supports the idea that the myocardium may redeploy embryonic mechanisms during pathological conditions in the adult to induce new vascular growth.14 Although hypoxia can be an underlying trigger for VEGF-A expression, the mechanisms by which VEGFR2 expression is modulated is not yet known. One of the critical regulators of VEGF-A and VEGFR2 expression/activation in endothelial cells are mechanical forces, generated by shear stress and mechanical strain.19–22 Because the heart tissue is continuously exposed to mechanical forces, it is plausible that mechanosignaling can play a significant role in angiogenesis, as previously demonstrated.23,24

Figure.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure.

Schematic of the proposed mechanism of endocardial flower formation and endothelial plasticity in the post–myocardial infarction (MI) endocardium. Ligation of the left anterior descending artery induces patchy expression of VEGFR2 (vascular endothelial growth factor receptor 2) in endocardial cells (beige) 3 days post MI. At the same time, hypoxia in the infarction/border zone may induce VEGF-A (vascular endothelial growth factor-A) expression creating a VEGF-A gradient (red arrow) in the direction opposite to oxygen gradient (black arrow). The VEGF-A gradient, together with mechanical forces, may induce sprouting angiogenesis in these VEGFR2 expressing endocardial cells (light green) with the appearance of tip cells (cell with projections). These cells then recruit stalk cells (dark green) to form endocardial flowers, with distinct connecting vessels 7 days post MI. Endocardial flowers exhibit Cx40-GFP (green fluorescent protein) expression and clustering of smooth muscle cells (SMCs) at this stage and progressively acquire the arterial phenotype. Genetic tracing experiments with Cx40-Cre; RYFP mice revealed the presence of YFP (yellow fluorescent protein) expressing endothelial cells (pre-existing) in a subset of RFP (red fluorescent protein)-positive endocardial flowers (new), suggesting that arteriogenesis also occurs by outgrowth of pre-existing coronary arteries.

Clinical Significance and Future Perspective

The answer to the second question is more pertinent and complicated. What is the functional significance of endocardial flowers? Do they supply blood to restrict the damage caused by an infarction and preserve cardiac function? Time course analysis revealed that endocardial flowers appeared at day 7 post MI and peaked at day 14, implying that they may participate in the initial prevention of damage to the infarcted myocardium as well as in the preservation of cardiac function. However, the current study is somewhat limited because cardiac function measurements were not performed, which may reveal whether endocardial flowers are indeed beneficial. One of the reasons for the limited success of therapeutic angiogenesis could be our limited understanding of the mechanism behind coronary revascularization. The findings from this study identify the endocardium as a source for de novo endothelial cells in the adult heart, as well as pre-existing vessels from coronary arteries. The molecular mechanism underlying this process seems to be the VEGF-A/VEGFR2 signaling pathway that induces angiogenesis and arteriogenesis from the endocardium (Figure), as demonstrated in embryonic cardiovascular growth. The process of redeployment of ontogenic mechanisms in pathological conditions seem to be common step,25–27 and understanding this molecular machinery in the adult heart could provide new avenues for future therapeutics in revascularization of the injured myocardium. In conclusion, the big question is can flowers repair a broken heart? They may or may not, but they definitely bring a smile to one’s face. Likewise, endocardial flowers may not repair or revascularize the damaged myocardium but they provide a potential avenue for therapies aimed at mending broken hearts.

Sources of Funding

This work was supported by American Heart Association Grant-in-Aid (14GRNT20380935); the National Institutes of Health (NIH-R15 [1R15HL106442-01]) and start-up funds from NEOMED (Dr Thodeti).

Disclosures

None.

Footnotes

  • The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association

  • © 2015 American Heart Association, Inc.

References

  1. 1.↵
    1. Zhang H,
    2. van Olden C,
    3. Sweeney D,
    4. Martin-Rendon E.
    Blood vessel repair and regeneration in the ischaemic heart. Open Heart. 2014;1:e000016. doi: 10.1136/openhrt-2013-000016.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Wu KH,
    2. Han ZC,
    3. Mo XM,
    4. Zhou B.
    Cell delivery in cardiac regenerative therapy. Ageing Res Rev. 2012;11:32–40. doi: 10.1016/j.arr.2011.06.002.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. van der Laan AM,
    2. Piek JJ,
    3. van Royen N.
    Targeting angiogenesis to restore the microcirculation after reperfused MI. Nat Rev Cardiol. 2009;6:515–523. doi: 10.1038/nrcardio.2009.103.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Tous E,
    2. Purcell B,
    3. Ifkovits JL,
    4. Burdick JA.
    Injectable acellular hydrogels for cardiac repair. J Cardiovasc Transl Res. 2011;4:528–542. doi: 10.1007/s12265-011-9291-1.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Tomanek RJ,
    2. Schatteman GC.
    Angiogenesis: new insights and therapeutic potential. Anat Rec. 2000;261:126–135.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Syed IS,
    2. Sanborn TA,
    3. Rosengart TK.
    Therapeutic angiogenesis: a biologic bypass. Cardiology. 2004;101:131–143. doi: 10.1159/000075994.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Ahn A,
    2. Frishman WH,
    3. Gutwein A,
    4. Passeri J,
    5. Nelson M.
    Therapeutic angiogenesis: a new treatment approach for ischemic heart disease–Part II. Cardiol Rev. 2008;16:219–229. doi: 10.1097/CRD.0b013e3181620e50.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Ahn A,
    2. Frishman WH,
    3. Gutwein A,
    4. Passeri J,
    5. Nelson M.
    Therapeutic angiogenesis: a new treatment approach for ischemic heart disease–part I. Cardiol Rev. 2008;16:163–171. doi: 10.1097/CRD.0b013e3181620e3b.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Simons M,
    2. Bonow RO,
    3. Chronos NA,
    4. Cohen DJ,
    5. Giordano FJ,
    6. Hammond HK,
    7. Laham RJ,
    8. Li W,
    9. Pike M,
    10. Sellke FW,
    11. Stegmann TJ,
    12. Udelson JE,
    13. Rosengart TK.
    Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation. 2000;102:E73–E86.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Tirziu D,
    2. Simons M.
    Angiogenesis in the human heart: gene and cell therapy. Angiogenesis. 2005;8:241–251. doi: 10.1007/s10456-005-9011-z.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Tian X,
    2. Pu WT,
    3. Zhou B.
    Cellular origin and developmental program of coronary angiogenesis. Circ Res. 2015;116:515–530. doi: 10.1161/CIRCRESAHA.116.305097.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Tian X,
    2. Hu T,
    3. Zhang H,
    4. et al
    . Subepicardial endothelial cells invade the embryonic ventricle wall to form coronary arteries. Cell Res. 2013;23:1075–1090. doi: 10.1038/cr.2013.83.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Red-Horse K,
    2. Ueno H,
    3. Weissman IL,
    4. Krasnow MA.
    Coronary arteries form by developmental reprogramming of venous cells. Nature. 2010;464:549–553. doi: 10.1038/nature08873.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Wu B,
    2. Zhang Z,
    3. Lui W,
    4. Chen X,
    5. Wang Y,
    6. Chamberlain AA,
    7. Moreno-Rodriguez RA,
    8. Markwald RR,
    9. O’Rourke BP,
    10. Sharp DJ,
    11. Zheng D,
    12. Lenz J,
    13. Baldwin HS,
    14. Chang CP,
    15. Zhou B.
    Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell. 2012;151:1083–1096. doi: 10.1016/j.cell.2012.10.023.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Miquerol L,
    2. Thireau J,
    3. Bideaux P,
    4. Sturny R,
    5. Richard S,
    6. Kelly RG.
    Endothelial plasticity drives arterial remodeling within the endocardium after myocardial infarction. Circ Res. 2015;116:1765–1771. doi: 10.1161/CIRCRESAHA.116.306476.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Miquerol L,
    2. Meysen S,
    3. Mangoni M,
    4. Bois P,
    5. van Rijen HV,
    6. Abran P,
    7. Jongsma H,
    8. Nargeot J,
    9. Gros D.
    Architectural and functional asymmetry of the His-Purkinje system of the murine heart. Cardiovasc Res. 2004;63:77–86. doi: 10.1016/j.cardiores.2004.03.007.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Beyer S,
    2. Kelly RG,
    3. Miquerol L.
    Inducible Cx40-Cre expression in the cardiac conduction system and arterial endothelial cells. Genesis. 2011;49:83–91. doi: 10.1002/dvg.20687.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Zhao T,
    2. Zhao W,
    3. Chen Y,
    4. Ahokas RA,
    5. Sun Y.
    Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc Res. 2010;80:188–194. doi: 10.1016/j.mvr.2010.03.014.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Abumiya T,
    2. Sasaguri T,
    3. Taba Y,
    4. Miwa Y,
    5. Miyagi M.
    Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CT-rich Sp1 binding site. Arterioscler Thromb Vasc Biol. 2002;22:907–913.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Jin ZG,
    2. Ueba H,
    3. Tanimoto T,
    4. Lungu AO,
    5. Frame MD,
    6. Berk BC.
    Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res. 2003;93:354–363. doi: 10.1161/01.RES.0000089257.94002.96.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Li J,
    2. Hampton T,
    3. Morgan JP,
    4. Simons M.
    Stretch-induced VEGF expression in the heart. J Clin Invest. 1997;100:18–24. doi: 10.1172/JCI119510.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Liu J,
    2. Agarwal S.
    Mechanical signals activate vascular endothelial growth factor receptor-2 to upregulate endothelial cell proliferation during inflammation. J Immunol. 2010;185:1215–1221. doi: 10.4049/jimmunol.0903660.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Mammoto A,
    2. Connor KM,
    3. Mammoto T,
    4. Yung CW,
    5. Huh D,
    6. Aderman CM,
    7. Mostoslavsky G,
    8. Smith LE,
    9. Ingber DE.
    A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature. 2009;457:1103–1108. doi: 10.1038/nature07765.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Song JW,
    2. Munn LL.
    Fluid forces control endothelial sprouting. Proc Natl Acad Sci U S A. 2011;108:15342–15347. doi: 10.1073/pnas.1105316108.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Alexander JM,
    2. Bruneau BG.
    Lessons for cardiac regeneration and repair through development. Trends Mol Med. 2010;16:426–434. doi: 10.1016/j.molmed.2010.06.003.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Chimenti I,
    2. Forte E,
    3. Angelini F,
    4. Giacomello A,
    5. Messina E.
    From ontogenesis to regeneration: learning how to instruct adult cardiac progenitor cells. Prog Mol Biol Transl Sci. 2012;111:109–137. doi: 10.1016/B978-0-12-398459-3.00005-8.
    OpenUrlPubMed
  27. 27.↵
    1. Mahmoud AI,
    2. Porrello ER.
    Turning back the cardiac regenerative clock: lessons from the neonate. Trends Cardiovasc Med. 2012;22:128–133. doi: 10.1016/j.tcm.2012.07.008.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
May 22, 2015, Volume 116, Issue 11
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Endocardial Flowers: A Bouquet of Arterial Endothelial Cells Generated From New and Pre-Existing Endothelial Cells Within the Endocardium of Infarcted Heart
    • Back in the Saddle: Redeployment of Developmental Mechanisms for Coronary Vessel Growth
    • Clinical Significance and Future Perspective
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    A Bouquet for a Broken Heart
    Charles K. Thodeti
    Circulation Research. 2015;116:1729-1731, originally published May 21, 2015
    https://doi.org/10.1161/CIRCRESAHA.115.306590

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    A Bouquet for a Broken Heart
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    A Bouquet for a Broken Heart
    Charles K. Thodeti
    Circulation Research. 2015;116:1729-1731, originally published May 21, 2015
    https://doi.org/10.1161/CIRCRESAHA.115.306590
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured